Navicyte boasts a range of R&D resources (both in vitro and in vivo) to evaluate therapeutic payload functionality in the Navicyte platform.

Providing a concise preclinical data package of CMC, safety, efficacy, and pharmacology outcomes for your therapeutic.

We work closely with leading academic institutions, funding agencies, and pharmaceutical innovators to accelerate translation. Our collaborations span:

• Preclinical studies with NIH investigators

• Early-stage grants and non-dilutive funding awards

• Industry partnerships in oncology and immunotherapy